reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Ironwood Pharmaceuticals Inc

IRWD · Nasdaq

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$103Mpublic float
2025-07-10most recent failure

Score over time

012202220232024202520262025-04-01 · score 12025-03-03 filed late (10-K) · material weakness2025-07-01 · score 12025-03-03 filed late (10-K) · material weakness2025-10-01 · score 22025-07-10 auditor change2025-03-03 filed late (10-K) · material weakness2026-01-01 · score 22025-07-10 auditor change2025-03-03 filed late (10-K) · material weakness2026-04-01 · score 12025-07-10 auditor change2026-07-01 · score 12025-07-10 auditor change

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Ironwood Pharmaceuticals, Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The Company is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense because of the circumstances described below. Based upon currently available information, the Company expects to report one or more material weaknesses in its internal controls and expects its internal control over financial reporting will be ineffective as of December 31, 2024. As a result, the Company requires additional time (i) to complete management’s assessment of the effectiveness of internal control over financial reporting and (ii) to complete certain processes and procedures to finalize the Form 10-K. The Company anticipates that the Form 10-K will be filed on or before the fifteenth calendar day following the prescribed due date

NT 10-K, filed 2025-03-03 · material weakness

What it filed

2025-07-10auditor changed or resigned SEC →

2025-03-03filed late (10-K)material weakness SEC →

Ironwood Pharmaceuticals, Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The Company is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense because of the circumstances described below. Based upon currently available information, the Company expects to report one or more material weaknesses in its internal controls and expects its internal control over financial reporting will be ineffective as of December 31, 2024. As a result, the Company requires additional time (i) to complete management’s assessment of the effectiveness of internal control over financial reporting and (ii) to complete certain processes and procedures to finalize the Form 10-K. The Company anticipates that the Form 10-K will be filed on or before the fifteenth calendar day following the prescribed due date

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com